SCHEMBL21921094

SCHEMBL21921094

CCc1cc2sccc2n1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 9/20 0.50
TSHR P16473 4/20 0.46
RAB9A P51151 3/20 0.46
ALOX15 P16050 2/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 2/20 0.43
MAPT P10636 4/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 2/20 0.41
RCOR1 Q9UKL0 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5036773 0.83 KDM1A (0.46) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL2272537 0.80 LMNA (0.47) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL20467138 0.78 KDM1A (0.40) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL435115 0.74 KDM1A (0.46) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL5041555 0.72 NTRK1 (0.44) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL5036813 0.72 KDM1A (0.46) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL19236928 0.69 TSHR (0.43) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL24188606 0.69 KDM1A (0.41) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL19229614 0.69 KDM1A (0.49) KDM1ATSHRRAB9AALOX15MAPK1
SCHEMBL5036630 0.69 MAPT (0.47) KDM1ATSHRRAB9AMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632899-A1 ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RaQualia Pharma Inc. (JP) 2020-04-08 EP disclosed